| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $1,304,386 | 2 | 100 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | 0 | $0 | 1 | $121,210 | $-121,210 |
| Wright Richard M. | Former Officer | 0 | $0 | 1 | $1.18M | $-1.18M |
Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the activity of the KIT receptor tyrosine kinase. CDX-1140 is a human agonist monoclonal antibody that targets CD40, a critical immune …
Over the last 12 months, insiders at Celldex Therapeutics, Inc. have bought $0 and sold $1.3M worth of Celldex Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Celldex Therapeutics, Inc. have bought $308,430 and sold $4.38M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 11,500 shares for transaction amount of $308,430 was made by Marucci Anthony S (PRESIDENT & CEO) on 2024‑11‑11.
| 2025-12-04 | Sale | Jimenez Freddy A. | SVP & GENERAL COUNSEL | 4,166 0.0062% | $29.09 | $121,210 | +5.61% | |
| 2025-11-13 | Sale | Wright Richard M. | Former Officer | 49,298 0.0751% | $24.00 | $1.18M | +30.71% | |
| 2025-08-13 | Sale | Jimenez Freddy A. | SVP & GENERAL COUNSEL | 771 0.0012% | $24.77 | $19,096 | +11.28% | |
| 2024-11-11 | Marucci Anthony S | PRESIDENT & CEO | 11,500 0.0178% | $26.82 | $308,430 | -13.49% | ||
| 2024-06-14 | Sale | Martin Samuel Bates | SVP AND CFO | 17,172 0.0259% | $35.42 | $608,315 | -25.61% | |
| 2024-06-14 | Sale | Crowley Elizabeth | SR. VP & CPDO | 30,000 0.0446% | $34.87 | $1.05M | -25.61% | |
| 2024-06-07 | Sale | Crowley Elizabeth | SR. VP & CPDO | 15,000 0.0226% | $35.06 | $525,873 | -25.71% | |
| 2024-06-07 | Sale | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 45,000 0.0682% | $35.26 | $1.59M | -25.71% | |
| 2024-06-03 | Sale | Jimenez Freddy A. | SVP & GENERAL COUNSEL | 8,006 0.0122% | $33.60 | $269,002 | -21.50% | |
| 2024-06-03 | Sale | Wright Richard M. | SR. VP & CCO | 46,844 0.0716% | $33.72 | $1.58M | -21.50% | |
| 2024-06-03 | Sale | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | 58,369 0.089% | $33.65 | $1.96M | -21.50% | |
| 2024-05-30 | Sale | Martin Samuel Bates | SVP AND CFO | 35,000 0.0538% | $34.05 | $1.19M | -21.48% | |
| 2024-05-30 | Sale | Crowley Elizabeth | SR. VP & CPDO | 38,597 0.0586% | $33.64 | $1.3M | -21.48% | |
| 2024-05-30 | Sale | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | 38,719 0.0595% | $34.07 | $1.32M | -21.48% | |
| 2024-05-30 | Sale | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 20,853 0.0317% | $33.73 | $703,334 | -21.48% | |
| 2022-12-07 | Sale | KELER TIBOR | EXECUTIVE VP & CSO | 16,860 0.0356% | $36.93 | $622,611 | -7.66% | |
| 2022-08-17 | Sale | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 19,000 0.0411% | $37.30 | $708,715 | -4.79% | |
| 2022-08-17 | Sale | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 1,355 0.0029% | $36.38 | $49,289 | -4.79% | |
| 2022-08-15 | Sale | Marucci Anthony S | PRESIDENT & CEO | 120,000 0.2564% | $37.66 | $4.52M | -6.57% | |
| 2022-08-15 | Sale | Wright Richard M. | SR. VP & CCO | 15,328 0.0328% | $37.71 | $578,048 | -6.57% |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | 30796 0.0392% | $914,949.16 | 1 | 3 | <0.0001% |
| RYAN UNA S | President & CEO | 898713 1.1444% | $26.7M | 2 | 0 | |
| SEARS PETER A | director | 72739 0.0926% | $2.16M | 1 | 0 | |
| ELLBERGER LARRY | director | 53500 0.0681% | $1.59M | 5 | 1 | +3.43% |
| Marucci Anthony S | PRESIDENT & CEO | 40284 0.0513% | $1.2M | 6 | 1 | +107.81% |
| PAREKH RAJESH R | director | 40000 0.0509% | $1.19M | 1 | 3 | <0.0001% |
| CATLIN AVERY W | Sr. VP & CFO | 35109 0.0447% | $1.04M | 5 | 3 | +20.69% |
| Martin Samuel Bates | SVP AND CFO | 28125 0.0358% | $835,593.75 | 1 | 6 | +500.67% |
| PENNER HARRY JR | director | 13416 0.0171% | $398,589.36 | 1 | 1 | +13.16% |
| LIPTON KAREN SHOOS | director | 13333 0.017% | $396,123.43 | 1 | 1 | +3.2% |
| Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | 13383 0.017% | $397,608.93 | 1 | 4 | +500.67% |
| MARINO JAMES J | director | 12704 0.0162% | $377,435.84 | 2 | 0 | +231.19% |
| KELER TIBOR | EXECUTIVE VP & CSO | 7357 0.0094% | $218,576.47 | 5 | 1 | +101.05% |
| SCHALLER CHARLES R | director | 5000 0.0064% | $148,550.00 | 4 | 0 | +1.11% |
| SHANNON TIMOTHY M | director | 3200 0.0041% | $95,072.00 | 1 | 0 | +11.03% |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 2115 0.0027% | $62,836.65 | 1 | 3 | +105.94% |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 1860 0.0024% | $55,260.60 | 1 | 4 | +275.1% |
| Davis Thomas Andrew | Sr. VP & CMO | 1489 0.0019% | $44,238.19 | 1 | 0 | +3.2% |
$21,345,882 | 83 | 94.45% | $2.19B | |
$52,263,649 | 70 | 1.18% | $2.49B | |
$108,353,116 | 49 | 15.41% | $2.17B | |
$586,486,795 | 47 | 4.28% | $2.38B | |
$154,047,855 | 36 | 79.21% | $2.21B |
| Increased Positions | 85 | +40.28% | 9M | +12.69% |
| Decreased Positions | 84 | -39.81% | 6M | -8.48% |
| New Positions | 26 | New | 2M | New |
| Sold Out Positions | 24 | Sold Out | 551,127 | Sold Out |
| Total Postitions | 212 | +0.47% | 73M | +4.2% |
| Kynam Capital Management, Lp | $164,781.00 | 9.24% | 6.1M | 0 | 0% | 2025-09-30 |
| Wellington Management Group Llp | $156,658.00 | 8.79% | 5.8M | +567,677 | +10.85% | 2025-09-30 |
| Blackrock, Inc. | $148,717.00 | 8.34% | 5.51M | -44,028 | -0.79% | 2025-09-30 |
| Fmr Llc | $134,026.00 | 7.52% | 4.96M | -477,030 | -8.77% | 2025-09-30 |
| Vanguard Group Inc | $106,813.00 | 5.99% | 3.95M | -2,532 | -0.06% | 2025-09-30 |
| Point72 Asset Management, L.P. | $105,175.00 | 5.9% | 3.89M | +1M | +38.98% | 2025-09-30 |
| Bellevue Group Ag | $96,093.00 | 5.39% | 3.56M | +250,100 | +7.56% | 2025-09-30 |
| Commodore Capital Lp | $81,795.00 | 4.59% | 3.03M | -421,665 | -12.22% | 2025-09-30 |
| State Street Corp | $76,766.00 | 4.31% | 2.84M | +436,639 | +18.15% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $64,352.00 | 3.61% | 2.38M | -1M | -37.59% | 2025-09-30 |